Study a Novel Klf10 (Kruppel-Like Transcription Factor10) Regulated Mechanism in Non-Alcoholic Fatty Liver Disease (NAFLD)

Pharmacology, Toxicology and Pharmaceutical Science

1. Nonalcoholic Fatty Liver 100%
2. Hydroxymethylglutaryl Coenzyme A Reductase Kinase 72%
3. Sterol Regulatory Element Binding Protein 1 63%
4. Non Insulin Dependent Diabetes Mellitus 27%
5. Liver Cell Carcinoma 18%
6. Liver Fibrosis 9%
7. Pancreas Cancer 9%
8. Liver Cirrhosis 9%
9. Insulin Receptor Substrate 1 9%
10. Tumor Suppressor Protein 9%
11. Prevalence 9%
12. Hyperinsulinemia 9%
13. Liver Dysfunction 9%
14. Syndrome 9%
15. Fatty Acid 9%
16. Diseases 9%